The first data from clinical trials of Moderna’s mRNA-based seasonal flu vaccine, released by the company Friday morning, were underwhelming — a finding that shows gene-based vaccines might not be a fix for all the problems with vaccine development.
Scooped by Online Marketing |
wise-to.com's comment,
December 17, 2021 11:35 PM
GOOD
Sign up to comment